Novel Approach to Cardiovascular Diseases: A Promising Probability of (Pro)Renin Receptor [(P)RR]

Author(s): Takashi Ando, Atsuhiro Ichihara.

Journal Name: Current Pharmaceutical Design

Volume 20 , Issue 14 , 2014

Become EABM
Become Reviewer

Abstract:

Inhibition of the renin-angiotensin system (RAS) has been shown to have beneficial effects in cardiovascular disease prognosis and therapy.Discovery of (pro)renin receptor [(P)RR] revealed that (P)RR upon binding to both renin or prorenin in their proenzyme inactive form made them enzymatically active, thus aiding the catalytic conversion of angiotensinogen (AGT) to angiotensin (Ang) I. This binding also transduces intracellular signal to the nucleus via various pathways. Our recent research elucidated the physiological roles of (P)RR in cell life, wherein it acts as an essential accessory protein of vacuolar H+-ATPase (V-ATPase) as well as an adaptor protein of Wnt signaling. The present review provides insights into a novel approach to cardiovascular diseases, which will open the gates to new therapeutic approaches for treating cardiovascular diseases.

Keywords: (Pro)renin receptor, vascuolar H+-ATPase, direct renin inhibitor.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 20
ISSUE: 14
Year: 2014
Page: [2371 - 2376]
Pages: 6
DOI: 10.2174/13816128113199990472
Price: $65

Article Metrics

PDF: 25